Gabriele Popperl

Stuttgart, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).

Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).

Journal: Molecular imaging and biology

Published: April 05, 2019

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.

Journal: Annals of hematology

Published: November 25, 2018

Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up.

Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 27, 2015

Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.

Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.

Journal: Journal of neurosurgery

Published: July 04, 2015

Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.

Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.

Journal: Neurology

Published: January 23, 2015

Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)

Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)

Journal: Nuklearmedizin. Nuclear medicine

Published: November 20, 2014

Neuroendocrine neoplasms of the distal jejunum and ileum

Neuroendocrine neoplasms of the distal jejunum and ileum

Journal: Der Pathologe

Published: March 28, 2014

Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update.

Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 19, 2013

Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.

Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.

Journal: Neuro-oncology

Published: October 24, 2012

Neuroendocrine tumours of the GI tract--data from the German NET Registry

Neuroendocrine tumours of the GI tract--data from the German NET Registry

Journal: Zentralblatt fur Chirurgie

Published: October 09, 2012

Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms.

Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms.

Journal: Pharmacopsychiatry

Published: May 09, 2012

Quantitative approaches to dopaminergic brain imaging.

Quantitative approaches to dopaminergic brain imaging.

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Published: March 31, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026